top of page
Executive Spotlights

Ron Renaud Appointed to Lead Cerevel Therapeutics as President and Chief Executive Officer

Cambridge, MA, May 3, 2023 (Globe Newswire) -- Cerevel Therapeutics has appointed Ron Renaud as its new CEO, succeeding Tony Coles, who will remain chairperson of the board. Renaud brings over 25 years of experience in biotech leadership, with prior CEO roles at companies such as Translate Bio and Idenix Pharmaceuticals.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page